Tag Archives: Luke Hospital

Data on Provectus's PV-10 to Be Presented at the HemOnc Today – Melanoma and Cutaneous Malignancies

By Business Wirevia The Motley Fool

Filed under:

Data on Provectus’s PV-10 to Be Presented at the HemOnc Today – Melanoma and Cutaneous Malignancies Conference on March 22, 2013

KNOXVILLE, Tenn.–(BUSINESS WIRE)– Provectus Pharmaceuticals, Inc. (OTCQB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 for metastatic melanoma will be included in a presentation at the HemOnc Today – Melanoma and Cutaneous Malignancies Conference on Friday, March 22, 2013 in New York.

Dr. Robert H.I. Andtbacka, Assistant Professor of Surgical Oncology, Huntsman Cancer Institute at the University of Utah in Salt Lake City, is scheduled to present during conference session on Local-Regional Therapy. His presentation, “Current Status of Injectable Therapy” begins at 1:55 p.m., EDT. This session will be moderated by Sanjiv S. Agarwala, MD, Principal Investigator for the Phase 2 trial of PV-10, and Chief of Medical Oncology and Hematology at St. Luke’s Hospital and Health Network in Bethlehem, PA.

Dr. Craig Dees, PhD, CEO of Provectus said, “We are pleased to be participating in this important conference. We expect Dr. Andtbacka’s presentation will support PV-10’s utility in the treatment of metastatic melanoma.”

About Provectus Pharmaceuticals, Inc.

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company’s other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus please visit the Company’s website at www.pvct.com or contact Porter, LeVay & Rose, Inc.

FORWARD-LOOKING STATEMENTS: The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The company undertakes no obligation to publicly revise these forward-looking statements to …read more
Source: FULL ARTICLE at DailyFinance

14 injured in massive fire at Kansas City shopping center, official says

A massive fire triggered by a gas explosion engulfed an entire block of an upscale Kansas City shopping district and injured 14 people, a city official said Tuesday evening.

City Manager Troy Schulte said he did not know of anyone being reported missing and had not heard of any fatalities.

The cause of the explosion was not immediately known, but Schulte said it is believed that an accident involving a utility contractor may have caused the blast.

Fox4KC.com reports that witnesses said the explosion was like an earthquake. The station said there were reports of blown-out windows and minor damage inside apartments near the blast.

Kansas City Fire Chief Paul Berardi said late Tuesday that cadaver dogs were searching the smoldering remains of a restaurant that burned to the ground following the explosion and blaze.

Berardi said the search for possible victims could take hours and that he expected his crews to be at the scene through the night.

While officials have said they have no reports of fatalities, Berardi noted, “I would always fear there are fatalities in a scene like this.”

Earlier Kansas City police had said the blast was caused by a car crashing into a gas main just after 6 p.m. Fire officials said later they were not aware of a crash being involved in the blast. Other witnesses noted street signs in the area indicated utility work was being done in the area, and a worker at a restaurant destroyed in the fire said the facility was being renovated at the time.

Police Sgt. Tony Sanders said the manager of JJ‘s restaurant was unable to account for three people, but it was unclear whether they were caught in the blaze or had left earlier.

“The first thing we need to be concerned about is the people that are injured,” said Mayor Sly James who said officials were in contact with Missouri Gas Energy.

James told Fox4KC.com that fire crews and first responders “have done a remarkable job getting here and working on this.”

Video showed dozens of firefighters and other emergency responders battling a massive blaze that appeared to have engulfed an entire block, with flames burning through the roofs. Black smoke swirled in the air and debris littered surrounding streets.

The University of Kansas Hospital was treating five people injured in the blast, said spokesman Bob Hallinan. He said one person was in critical condition, two were in serious condition and two others were expected to be released. He said all the injuries were traumatic, such as broken bones, rather than burns or smoke inhalation.

Kerry O’Connor, a spokeswoman for St. Luke’s Hospital, which is near the scene of the fire, said several patients were sent to the hospital. She said they haven’t been assessed yet but “they appear to be critical at this time.”

Fire officials did not immediately return a phone call seeking comment Tuesday evening.

The smell of gas remained very strong near the area long after the suspected explosion.

A phone message left Tuesday seeking comment from Missouri Gas Energy was not immediately returned.

Jim Ligon, a …read more
Source: FULL ARTICLE at Fox US News